Pub Date : 2026-03-11DOI: 10.1016/j.survophthal.2026.03.004
Alberto Quarta, Alessandro Feo, Giacomo Boscia, Alfonso Savastano, Francesco Boscia, Mario R Romano, Rodolfo Mastropasqua
Advances in cross-sectional and en face optical coherence tomography have revealed a spectrum of subtle inner retinal changes that occur in both surgical and non-surgical conditions. Among these, inner retinal dimples (IRDs), also referred to as dissociated optic nerve fiber layer (DONFL) appearance, concentric macular dark spots (CMDS), and transient swollen arcuate nerve fiber layer (SANFL) have been described in eyes undergoing internal limiting membrane (ILM) peeling, most commonly for macular hole or epiretinal membrane while paravascular inner retinal defects (PIRD), micro-holes, and clefts have been reported in highly myopic eyes and tractional conditions even without prior surgery. The multiplicity of terms, some modality-dependent, others descriptive of etiology has obscured the relationships among these entities, causing confusion in clinical interpretation and research communication. Herein, we propose a hypothesis-driven conceptual and terminological framework intended to reconcile these disparate observations within a coherent schema grounded in anatomy and imaging phenotype while recognizing that the available evidence remains predominantly retrospective and heterogeneous. By reviewing multimodal imaging studies we clarify that postoperative IRDs, DONFL, CMDS, and SANFL may reflect a remodeling response of the inner retina (largely due to ILM removal/peeling, either surgical or spontaneous) whereas PIRD and its variants stem from chronic biomechanical or tractional stress. The review examines their morphological characteristics, temporal evolution, and available data on structure-function correlations. Standardizing nomenclature and interpretation will enhance clarity in both surgical outcomes assessment and clinical management of myopic or tractional retinal disease.
{"title":"Inner retinal surface abnormalities: Imaging phenotypes, quantitative features, and mechanistic insights across surgical and nonsurgical conditions.","authors":"Alberto Quarta, Alessandro Feo, Giacomo Boscia, Alfonso Savastano, Francesco Boscia, Mario R Romano, Rodolfo Mastropasqua","doi":"10.1016/j.survophthal.2026.03.004","DOIUrl":"10.1016/j.survophthal.2026.03.004","url":null,"abstract":"<p><p>Advances in cross-sectional and en face optical coherence tomography have revealed a spectrum of subtle inner retinal changes that occur in both surgical and non-surgical conditions. Among these, inner retinal dimples (IRDs), also referred to as dissociated optic nerve fiber layer (DONFL) appearance, concentric macular dark spots (CMDS), and transient swollen arcuate nerve fiber layer (SANFL) have been described in eyes undergoing internal limiting membrane (ILM) peeling, most commonly for macular hole or epiretinal membrane while paravascular inner retinal defects (PIRD), micro-holes, and clefts have been reported in highly myopic eyes and tractional conditions even without prior surgery. The multiplicity of terms, some modality-dependent, others descriptive of etiology has obscured the relationships among these entities, causing confusion in clinical interpretation and research communication. Herein, we propose a hypothesis-driven conceptual and terminological framework intended to reconcile these disparate observations within a coherent schema grounded in anatomy and imaging phenotype while recognizing that the available evidence remains predominantly retrospective and heterogeneous. By reviewing multimodal imaging studies we clarify that postoperative IRDs, DONFL, CMDS, and SANFL may reflect a remodeling response of the inner retina (largely due to ILM removal/peeling, either surgical or spontaneous) whereas PIRD and its variants stem from chronic biomechanical or tractional stress. The review examines their morphological characteristics, temporal evolution, and available data on structure-function correlations. Standardizing nomenclature and interpretation will enhance clarity in both surgical outcomes assessment and clinical management of myopic or tractional retinal disease.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147460003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-11DOI: 10.1016/j.survophthal.2026.03.006
Clara Rizzo, Stefano Mercuri, Maria Cristina Savastano, Andrea Govetto, Cristina Nicolosi, Giulio Vicini, Francesco Faraldi, Gianni Virgili, Fabrizio Giansanti, Daniela Bacherini
Optical coherence tomography (OCT) has transformed retinal imaging, primarily focusing on the posterior pole; however, its application in assessing peripheral retinal lesions is an evolving field. Recent advances in widefield (WF) and ultra-widefield (UWF) OCT technology have significantly expanded the ability to image the peripheral retina, allowing for improved detection and characterization of peripheral retinal lesions. We evaluate the effectiveness of OCT in identifying peripheral retinal lesions, assessing vitreoretinal adhesions and tractions, aiding differential diagnosis, and guiding treatment strategies among studies published between 2006 and 2024. WF and UWF OCT have significantly enhanced the visualization and documentation of peripheral retinal abnormalities, facilitating more precise detection of retinal breaks, lattice degeneration, and vitreoretinal traction. These advancements have influenced clinical decisions, ranging from conservative monitoring to laser therapy or surgical intervention. Furthermore, OCT has provided valuable insights into the pathophysiology of these retinal disorders; however, several challenges persist, including the absence of standardized imaging protocols and variability in the interpretation of morphological findings. While peripheral OCT imaging enhances diagnostic accuracy and clinical management, broader adoption requires standardization of acquisition techniques and diagnostic criteria. We explore the role of WF and UWF OCT in visualizing peripheral retinal degenerations, describing their hallmark features on OCT, evaluating their diagnostic value, clinical impact, and current limitations. Future research should focus on refining imaging protocols, developing automated diagnostic tools, and evaluating the prognostic significance of peripheral OCT findings to improve patient outcomes.
{"title":"Peripheral retinal degenerations: A review of peripheral optical coherence tomography applications in their diagnosis and visualization.","authors":"Clara Rizzo, Stefano Mercuri, Maria Cristina Savastano, Andrea Govetto, Cristina Nicolosi, Giulio Vicini, Francesco Faraldi, Gianni Virgili, Fabrizio Giansanti, Daniela Bacherini","doi":"10.1016/j.survophthal.2026.03.006","DOIUrl":"https://doi.org/10.1016/j.survophthal.2026.03.006","url":null,"abstract":"<p><p>Optical coherence tomography (OCT) has transformed retinal imaging, primarily focusing on the posterior pole; however, its application in assessing peripheral retinal lesions is an evolving field. Recent advances in widefield (WF) and ultra-widefield (UWF) OCT technology have significantly expanded the ability to image the peripheral retina, allowing for improved detection and characterization of peripheral retinal lesions. We evaluate the effectiveness of OCT in identifying peripheral retinal lesions, assessing vitreoretinal adhesions and tractions, aiding differential diagnosis, and guiding treatment strategies among studies published between 2006 and 2024. WF and UWF OCT have significantly enhanced the visualization and documentation of peripheral retinal abnormalities, facilitating more precise detection of retinal breaks, lattice degeneration, and vitreoretinal traction. These advancements have influenced clinical decisions, ranging from conservative monitoring to laser therapy or surgical intervention. Furthermore, OCT has provided valuable insights into the pathophysiology of these retinal disorders; however, several challenges persist, including the absence of standardized imaging protocols and variability in the interpretation of morphological findings. While peripheral OCT imaging enhances diagnostic accuracy and clinical management, broader adoption requires standardization of acquisition techniques and diagnostic criteria. We explore the role of WF and UWF OCT in visualizing peripheral retinal degenerations, describing their hallmark features on OCT, evaluating their diagnostic value, clinical impact, and current limitations. Future research should focus on refining imaging protocols, developing automated diagnostic tools, and evaluating the prognostic significance of peripheral OCT findings to improve patient outcomes.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147460032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-11DOI: 10.1016/j.survophthal.2026.03.009
Anna M Busza, Clayton E Lyons, Nikoo Hamzeh, Saeed Mohammadi, Manjot K Gill
Optical coherence tomography angiography (OCT-A) is a non-invasive retinal imaging tool with expanding clinical and research applications, including potential uses as a biomarker for systemic diseases. The influence of age on OCT-A parameters, however, remains incompletely understood. To address this, we conducted a comprehensive review across seven databases, screening 271 full-text articles, of which 156 met inclusion criteria. Extracted data included participant demographics, study design, OCT-A device type, measured parameters, and outcomes across retinal layers in the macula and optic nerve head. Normative OCT-A values for pediatric and older adult populations were also reviewed. Evidence consistently demonstrated an age-related decline in macular vessel density among adults, even after accounting for signal strength. In contrast, pediatric studies showed variable associations between age and vascular parameters. Across all populations, foveal avascular zone size remained largely unaffected by age. These findings highlight the importance of considering age when interpreting OCT-A metrics in both clinical and research settings.
{"title":"Optical coherence tomography angiography in pediatric and adult populations: A comprehensive review.","authors":"Anna M Busza, Clayton E Lyons, Nikoo Hamzeh, Saeed Mohammadi, Manjot K Gill","doi":"10.1016/j.survophthal.2026.03.009","DOIUrl":"https://doi.org/10.1016/j.survophthal.2026.03.009","url":null,"abstract":"<p><p>Optical coherence tomography angiography (OCT-A) is a non-invasive retinal imaging tool with expanding clinical and research applications, including potential uses as a biomarker for systemic diseases. The influence of age on OCT-A parameters, however, remains incompletely understood. To address this, we conducted a comprehensive review across seven databases, screening 271 full-text articles, of which 156 met inclusion criteria. Extracted data included participant demographics, study design, OCT-A device type, measured parameters, and outcomes across retinal layers in the macula and optic nerve head. Normative OCT-A values for pediatric and older adult populations were also reviewed. Evidence consistently demonstrated an age-related decline in macular vessel density among adults, even after accounting for signal strength. In contrast, pediatric studies showed variable associations between age and vascular parameters. Across all populations, foveal avascular zone size remained largely unaffected by age. These findings highlight the importance of considering age when interpreting OCT-A metrics in both clinical and research settings.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147460084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-10DOI: 10.1016/j.survophthal.2026.03.003
Tristan Jurkiewicz, Anne-Sophie Marty
Purpose: We present the life and work of William White Cooper, with a focus on his 1850 study On the conical cornea, the earliest known multicentre epidemiological investigation of keratoconus. We contextualise Cooper's contribution within mid-19th-century ophthalmology, reassessing his findings in light of modern epidemiological knowledge.
Methods: Historical research was conducted using Gallica (the digital platform of the National Library of France (BnF)) and the historical resources of The Lancet website. The keywords used were 'conical cornea' or 'keratoconus,' which were the most common names for keratoconus.
Results: William White Cooper, a leading Victorian ophthalmic surgeon and later Surgeon-Oculist in Ordinary to Queen Victoria, conducted what appears to be the first epidemiological study of keratoconus, nearly a century before the earliest study typically cited in modern literature. Drawing on data from multiple ophthalmic hospitals across England, Scotland, Ireland, and Macao, Cooper compiled prevalence figures from over 200,000 examined patients between 1814 and 1850. Prevalence rates, recalculated for comparison with modern standards, varied markedly between regions: from 0 in Edinburgh to 254.0 cases per 100,000 in Plymouth, with an overall prevalence of 85.92 per 100,000 for the United Kingdom. The highest prevalence was observed in Macao (324.15 per 100,000), leading Cooper to hypothesise that warmer climates might favor the occurrence of keratoconus. Despite the diagnostic limitations of the period, these values are strikingly close to those reported in parts of modern Europe, underscoring the scale and relevance of his pioneering work.
Conclusion: Cooper's 1850 investigation represents the earliest known multicentre epidemiological study of keratoconus, predating modern reports by nearly a century. Despite methodological limitations inherent to the mid-19th century, his findings anticipated contemporary prevalence patterns and introduced the hypothesis of environmental influences on disease occurrence. This work not only enriches the historical record of keratoconus, but also highlights the enduring value of early clinical observation in shaping epidemiological understanding.
目的:介绍威廉·怀特·库珀的生平和工作,重点介绍他1850年对圆锥角膜的研究,这是已知最早的圆锥角膜多中心流行病学调查。本文旨在将库珀对19世纪中期眼科的贡献置于背景中,根据现代流行病学知识重新评估他的发现。方法:使用Gallica(法国国家图书馆数字平台)和the Lancet网站的历史资源进行历史研究。使用的关键词是“圆锥角膜”或“圆锥角膜”,这是圆锥角膜最常见的名称。结果:威廉·怀特·库珀(William White Cooper)是维多利亚时代著名的眼科医生,后来成为维多利亚女王时期的普通眼科医生,他进行了第一次关于圆锥角膜的流行病学研究,比现代文献中最早的研究早了近一个世纪。根据来自英格兰、苏格兰、爱尔兰和澳门多家眼科医院的数据,库珀汇编了1814年至1850年间接受检查的20多万名患者的患病率数据。重新计算的流行率与现代标准进行了比较,不同地区的流行率差异很大:从爱丁堡的0例到普利茅斯的254.0例/ 10万例,英国的总体流行率为85.92 / 10万。澳门的患病率最高(每10万人中有324.15人),这使得Cooper假设温暖的气候可能有利于圆锥角膜的发生。尽管那个时期的诊断存在局限性,但这些价值与现代欧洲部分地区的报告惊人地接近,突显了他开创性工作的规模和相关性。结论:库珀1850年的调查代表了已知最早的圆锥角膜多中心流行病学研究,比现代报告早了近一个世纪。尽管19世纪中期固有的方法局限性,但他的发现预测了当代的流行模式,并提出了环境影响疾病发生的假设。这项工作不仅丰富了圆锥角膜的历史记录,而且突出了早期临床观察在形成流行病学认识方面的持久价值。
{"title":"William W. Cooper and his epidemiological study \"On the conical cornea\" of 1850.","authors":"Tristan Jurkiewicz, Anne-Sophie Marty","doi":"10.1016/j.survophthal.2026.03.003","DOIUrl":"10.1016/j.survophthal.2026.03.003","url":null,"abstract":"<p><strong>Purpose: </strong>We present the life and work of William White Cooper, with a focus on his 1850 study On the conical cornea, the earliest known multicentre epidemiological investigation of keratoconus. We contextualise Cooper's contribution within mid-19th-century ophthalmology, reassessing his findings in light of modern epidemiological knowledge.</p><p><strong>Methods: </strong>Historical research was conducted using Gallica (the digital platform of the National Library of France (BnF)) and the historical resources of The Lancet website. The keywords used were 'conical cornea' or 'keratoconus,' which were the most common names for keratoconus.</p><p><strong>Results: </strong>William White Cooper, a leading Victorian ophthalmic surgeon and later Surgeon-Oculist in Ordinary to Queen Victoria, conducted what appears to be the first epidemiological study of keratoconus, nearly a century before the earliest study typically cited in modern literature. Drawing on data from multiple ophthalmic hospitals across England, Scotland, Ireland, and Macao, Cooper compiled prevalence figures from over 200,000 examined patients between 1814 and 1850. Prevalence rates, recalculated for comparison with modern standards, varied markedly between regions: from 0 in Edinburgh to 254.0 cases per 100,000 in Plymouth, with an overall prevalence of 85.92 per 100,000 for the United Kingdom. The highest prevalence was observed in Macao (324.15 per 100,000), leading Cooper to hypothesise that warmer climates might favor the occurrence of keratoconus. Despite the diagnostic limitations of the period, these values are strikingly close to those reported in parts of modern Europe, underscoring the scale and relevance of his pioneering work.</p><p><strong>Conclusion: </strong>Cooper's 1850 investigation represents the earliest known multicentre epidemiological study of keratoconus, predating modern reports by nearly a century. Despite methodological limitations inherent to the mid-19th century, his findings anticipated contemporary prevalence patterns and introduced the hypothesis of environmental influences on disease occurrence. This work not only enriches the historical record of keratoconus, but also highlights the enduring value of early clinical observation in shaping epidemiological understanding.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-10DOI: 10.1016/j.survophthal.2026.03.005
I-Ming Wang, I-Lun Tsai
Mucosa-associated lymphoid tissue (MALT) lymphoma is a subtype of indolent extranodal B-cell non-Hodgkin lymphoma. Orbital and conjunctival MALT lymphomas (OAML) are the most common primary ocular adnexal lymphomas, while gastric MALT lymphoma remains a prototypical site linked to Helicobacter pylori infection. Despite the disparate anatomical locations, mounting evidence suggests a shared pathogenesis, including chronic antigenic stimulation, lymphoid accumulation, and genetic events. We explore the epidemiologic, pathophysiologic, and molecular connections between OAML and gastric MALT lymphoma, with particular emphasis on the therapeutic implications. The role of H. pylori as a driver of gastric lymphomagenesis is well-established, and antibiotic eradication therapy has revolutionized treatment. By contrast, the evidence for microbial triggers and antibiotic responsiveness in OAML remains equivocal, although Chlamydia psittaci has been proposed in some populations. We comprehensively evaluate treatment modalities for OAML, including watchful waiting, antibiotic therapy, low-dose radiotherapy, immunochemotherapy (e.g., rituximab, bendamustine), and targeted agents. The differences in natural history, treatment response, and relapse patterns between gastric and ocular MALTomas are reviewed, and a proposed treatment algorithm is presented. Finally, we highlight knowledge gaps and future directions, including molecular profiling, predictive biomarkers, and microbiome-targeted interventions.
{"title":"Comparative pathogenesis and management of orbital/conjunctival and gastric MALT lymphoma: Microbial drivers, molecular mechanisms, and therapeutic implications.","authors":"I-Ming Wang, I-Lun Tsai","doi":"10.1016/j.survophthal.2026.03.005","DOIUrl":"10.1016/j.survophthal.2026.03.005","url":null,"abstract":"<p><p>Mucosa-associated lymphoid tissue (MALT) lymphoma is a subtype of indolent extranodal B-cell non-Hodgkin lymphoma. Orbital and conjunctival MALT lymphomas (OAML) are the most common primary ocular adnexal lymphomas, while gastric MALT lymphoma remains a prototypical site linked to Helicobacter pylori infection. Despite the disparate anatomical locations, mounting evidence suggests a shared pathogenesis, including chronic antigenic stimulation, lymphoid accumulation, and genetic events. We explore the epidemiologic, pathophysiologic, and molecular connections between OAML and gastric MALT lymphoma, with particular emphasis on the therapeutic implications. The role of H. pylori as a driver of gastric lymphomagenesis is well-established, and antibiotic eradication therapy has revolutionized treatment. By contrast, the evidence for microbial triggers and antibiotic responsiveness in OAML remains equivocal, although Chlamydia psittaci has been proposed in some populations. We comprehensively evaluate treatment modalities for OAML, including watchful waiting, antibiotic therapy, low-dose radiotherapy, immunochemotherapy (e.g., rituximab, bendamustine), and targeted agents. The differences in natural history, treatment response, and relapse patterns between gastric and ocular MALTomas are reviewed, and a proposed treatment algorithm is presented. Finally, we highlight knowledge gaps and future directions, including molecular profiling, predictive biomarkers, and microbiome-targeted interventions.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-10DOI: 10.1016/j.survophthal.2026.03.001
Kourosh Sheibani, Kia Bayat, Zhale Rajavi, Saeid Abdi, Firouze Hatami, Sina Khosravi Mirzaei, Homayoun Nikkhah, Azadeh Haseli-Mofrad, Mohammad Hasan Shahriari, Niloufar Bineshfar, Hamideh Sabbaghi
We synthesized current evidence on the spectrum of ophthalmic alterations in prematurely born children without retinopathy of prematurity (ROP). A literature review was conducted in accordance with PRISMA guidelines. Scopus, PubMed, Web of Science, and Cochrane Library were searched for English-language studies published between 2000 and 2025. Eligible studies included observational designs reporting ophthalmic outcomes in infants born before 37 weeks of gestation without ROP. A total of 32 studies consisting of 4,548 individuals were investigated. Data were qualitatively synthesized across visual, refractive, anterior segment, and posterior segment domains. Mean visual acuity in preterm children without ROP ranged from -0.06 to 0.16 LogMAR and was generally comparable to term peers. Stereoacuity was reduced but showed improvement with age. Strabismus was reported in 5-20% of cases, increasing with age, and most commonly presented as esotropia. Nystagmus incidence ranged from 0-14%. Anisometropia was reported in 1.4-16.7% of preterm children without ROP, with one study demonstrating a higher prevalence compared to term peers. Hyperopia was highly prevalent, ranging from 20.9% to 86.2%, while astigmatism was reported in 14.1-65.1% of cases. Astigmatism predominated at one year of age, whereas hyperopia became the most common refractive error by six years. Hyperopia tends to increase with age, astigmatism gradually declines, and myopia rates remain relatively stable. Anterior segment findings in infancy included greater central corneal thickness, smaller corneal diameter, reduced axial length, shallower anterior chamber depth, and increased lens thickness. Posterior segment alterations included thicker central macula and focal thinning of the retinal nerve fiber layer in some reports. Premature birth, even in the absence of ROP, is independently associated with persistent structural and functional ophthalmic alterations. These findings highlight the need for long-term surveillance and early ophthalmologic intervention in this population.
我们综合了目前关于无早产儿视网膜病变(ROP)的早产儿眼部改变谱的证据。根据PRISMA指南进行文献综述。Scopus、PubMed、Web of Science和Cochrane Library检索了2000年至2025年间发表的英语研究。符合条件的研究包括观察性设计,报告妊娠37周前出生的无ROP婴儿的眼科结果。总共调查了32项研究,包括4,548人。定性地综合了视觉、屈光、前节和后节区域的数据。没有ROP的早产儿的平均视力范围为-0.06至0.16 LogMAR,一般与足月同龄人相当。立体视敏度随年龄增长而降低,但有改善。5-20%的病例有斜视,随年龄增长而增加,最常表现为内斜视。眼球震颤发生率为0-14%。据报道,1.4-16.7%的无ROP早产儿有屈光参差,一项研究表明,与足月同龄人相比,屈光参差的患病率更高。远视发生率为20.9% ~ 86.2%,散光发生率为14.1% ~ 65.1%。散光在一岁时占主导地位,而远视在六岁时成为最常见的屈光不正。远视随年龄增长而增加,散光逐渐减弱,近视率保持相对稳定。婴儿期前段的表现包括角膜中央厚度增大,角膜直径减小,角膜轴长减小,前房深度变浅,晶状体厚度增加。后段病变包括中央黄斑变厚和视网膜神经纤维层局灶性变薄。早产,即使在没有ROP的情况下,也与持续的眼科结构和功能改变独立相关。这些发现强调了对这一人群进行长期监测和早期眼科干预的必要性。
{"title":"Ophthalmic manifestations in preterm children without retinopathy of prematurity: A review.","authors":"Kourosh Sheibani, Kia Bayat, Zhale Rajavi, Saeid Abdi, Firouze Hatami, Sina Khosravi Mirzaei, Homayoun Nikkhah, Azadeh Haseli-Mofrad, Mohammad Hasan Shahriari, Niloufar Bineshfar, Hamideh Sabbaghi","doi":"10.1016/j.survophthal.2026.03.001","DOIUrl":"https://doi.org/10.1016/j.survophthal.2026.03.001","url":null,"abstract":"<p><p>We synthesized current evidence on the spectrum of ophthalmic alterations in prematurely born children without retinopathy of prematurity (ROP). A literature review was conducted in accordance with PRISMA guidelines. Scopus, PubMed, Web of Science, and Cochrane Library were searched for English-language studies published between 2000 and 2025. Eligible studies included observational designs reporting ophthalmic outcomes in infants born before 37 weeks of gestation without ROP. A total of 32 studies consisting of 4,548 individuals were investigated. Data were qualitatively synthesized across visual, refractive, anterior segment, and posterior segment domains. Mean visual acuity in preterm children without ROP ranged from -0.06 to 0.16 LogMAR and was generally comparable to term peers. Stereoacuity was reduced but showed improvement with age. Strabismus was reported in 5-20% of cases, increasing with age, and most commonly presented as esotropia. Nystagmus incidence ranged from 0-14%. Anisometropia was reported in 1.4-16.7% of preterm children without ROP, with one study demonstrating a higher prevalence compared to term peers. Hyperopia was highly prevalent, ranging from 20.9% to 86.2%, while astigmatism was reported in 14.1-65.1% of cases. Astigmatism predominated at one year of age, whereas hyperopia became the most common refractive error by six years. Hyperopia tends to increase with age, astigmatism gradually declines, and myopia rates remain relatively stable. Anterior segment findings in infancy included greater central corneal thickness, smaller corneal diameter, reduced axial length, shallower anterior chamber depth, and increased lens thickness. Posterior segment alterations included thicker central macula and focal thinning of the retinal nerve fiber layer in some reports. Premature birth, even in the absence of ROP, is independently associated with persistent structural and functional ophthalmic alterations. These findings highlight the need for long-term surveillance and early ophthalmologic intervention in this population.</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147445248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This systematic review evaluates conbercept, ranibizumab, and laser therapy for retinopathy of prematurity (ROP) through 53 studies (14 RCTs, 29 retrospective, 10 single-arm) involving 8,787 eyes. Primary endpoints included inactive ROP rates (resolution of plus disease/vascular tortuosity), disease regression, recurrence rates, and retreatment needs, with safety assessments covering ocular complications (retinal detachment, vitreous hemorrhage) and systemic events (apnea, arrhythmias). Exploratory analyses examined conbercept dosing regimens (0.15mg, 0.25mg, 0.3mg). Conbercept showed superior cumulative efficacy (SUCRA=0.815) versus laser (0.533) and ranibizumab (0.152), though initial treatment responses were comparable. Ranibizumab had higher recurrence (RR=3.62, 95%CI:1.31-11.64) and retreatment rates (RR=2.31, 95%CI:1.18-5.55) than laser, which ranked best for preventing recurrence (SUCRA=0.792). Conbercept's ocular AE rate (3.85%) was lower than laser (9.82%) and ranibizumab (5.03%), with fewer systemic complications (3.49% NICU admissions vs 42.17% for laser). Dose-response analysis revealed 0.25mg conbercept balanced efficacy (82.70% inactivity) and safety (3.84% AEs), while 0.3mg showed peak efficacy (90.7%) but limited safety data. Higher doses reduced recurrence (22.97% at 0.15mg vs 17.00% at 0.25mg).
本系统综述通过涉及8,787只眼睛的53项研究(14项随机对照试验,29项回顾性研究,10项单臂研究)评估了雷尼单抗、雷尼单抗和激光治疗早产儿视网膜病变(ROP)的疗效。主要终点包括无活性ROP率(疾病/血管弯曲的消退)、疾病消退、复发率和再治疗需求,安全性评估包括眼部并发症(视网膜脱离、玻璃体出血)和全身事件(呼吸暂停、心律失常)。探索性分析检查了概念给药方案(0.15mg, 0.25mg, 0.3mg)。Conbercept的累积疗效(SUCRA=0.815)优于激光(0.533)和雷尼单抗(0.152),尽管初始治疗反应相当。雷尼单抗的复发率(RR=3.62, 95%CI:1.31-11.64)和复治率(RR=2.31, 95%CI:1.18-5.55)均高于激光,在预防复发方面位居第一(SUCRA=0.792)。Conbercept的眼部AE发生率(3.85%)低于激光(9.82%)和雷尼单抗(5.03%),系统性并发症更少(NICU入院率为3.49%,激光为42.17%)。剂量反应分析显示,0.25mg的概念平衡了疗效(82.70%无活性)和安全性(3.84% ae), 0.3mg的疗效达到峰值(90.7%),但安全性数据有限。高剂量降低了复发率(0.15mg时22.97% vs 0.25mg时17.00%)。
{"title":"Efficacy and safety of conbercept, ranibizumab and laser in retinopathy of prematurity: a systematic review and network meta-analysis.","authors":"Dandan Linghu, Xuemei Zhu, Jianhong Liang, Yong Cheng","doi":"10.1016/j.survophthal.2026.03.002","DOIUrl":"https://doi.org/10.1016/j.survophthal.2026.03.002","url":null,"abstract":"<p><p>This systematic review evaluates conbercept, ranibizumab, and laser therapy for retinopathy of prematurity (ROP) through 53 studies (14 RCTs, 29 retrospective, 10 single-arm) involving 8,787 eyes. Primary endpoints included inactive ROP rates (resolution of plus disease/vascular tortuosity), disease regression, recurrence rates, and retreatment needs, with safety assessments covering ocular complications (retinal detachment, vitreous hemorrhage) and systemic events (apnea, arrhythmias). Exploratory analyses examined conbercept dosing regimens (0.15mg, 0.25mg, 0.3mg). Conbercept showed superior cumulative efficacy (SUCRA=0.815) versus laser (0.533) and ranibizumab (0.152), though initial treatment responses were comparable. Ranibizumab had higher recurrence (RR=3.62, 95%CI:1.31-11.64) and retreatment rates (RR=2.31, 95%CI:1.18-5.55) than laser, which ranked best for preventing recurrence (SUCRA=0.792). Conbercept's ocular AE rate (3.85%) was lower than laser (9.82%) and ranibizumab (5.03%), with fewer systemic complications (3.49% NICU admissions vs 42.17% for laser). Dose-response analysis revealed 0.25mg conbercept balanced efficacy (82.70% inactivity) and safety (3.84% AEs), while 0.3mg showed peak efficacy (90.7%) but limited safety data. Higher doses reduced recurrence (22.97% at 0.15mg vs 17.00% at 0.25mg).</p>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":" ","pages":""},"PeriodicalIF":5.9,"publicationDate":"2026-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147378524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-09-20DOI: 10.1016/j.survophthal.2025.09.017
Alberto Quarta , Alessandro Feo , Giulia Corradetti , Marko M. Popovic , SriniVas R. Sadda
The double-layer sign (DLS) is an emerging optical coherence tomography (OCT) biomarker of growing diagnostic and prognostic relevance in retinal and chorioretinal diseases, including age-related macular degeneration, pachychoroid spectrum disorders. Multimodal imaging, particularly OCT angiography (OCTA), has enhanced our ability to characterize DLS and its role in disease progression and treatment response. DLS is identified as a separation between the retinal pigment epithelium (RPE) and Bruch's membrane, with overlapping phenotypic presentations including flat irregular pigment epithelial detachment (FIPED) and shallow irregular retinal pigment epithelial elevation. These signs are often associated with vascularized lesions that demonstrate increased DLS thickness, irregular contours, and heterogeneous reflectivity. OCTA offers superior sensitivity and specificity for detecting subclinical macular neovascularization compared to dye-based angiography, which may underestimate nonexudative neovascularization. Additionally, indocyanine green angiography remains crucial for identifying branching vascular networks and polypoidal lesions, especially in polypoidal choroidal vasculopathy. In pachychoroid diseases, such as chronic central serous chorioretinopathy, the presence of FIPED/DLS can indicate underlying neovascularization, which may benefit from combination therapy with anti-vascular endothelial growth factor agents. We discuss the multimodal imaging characteristics, prognostic significance, and clinical relevance of DLS across various retinal and chorioretinal disorders.
{"title":"Double layer sign in chorioretinal diseases: Clinical significance and implications from multimodal imaging","authors":"Alberto Quarta , Alessandro Feo , Giulia Corradetti , Marko M. Popovic , SriniVas R. Sadda","doi":"10.1016/j.survophthal.2025.09.017","DOIUrl":"10.1016/j.survophthal.2025.09.017","url":null,"abstract":"<div><div>The double-layer sign (DLS) is an emerging optical coherence tomography (OCT) biomarker of growing diagnostic and prognostic relevance in retinal and chorioretinal diseases, including age-related macular degeneration, pachychoroid spectrum disorders. Multimodal imaging, particularly OCT angiography (OCTA), has enhanced our ability to characterize DLS and its role in disease progression and treatment response. DLS is identified as a separation between the retinal pigment epithelium (RPE) and Bruch's membrane, with overlapping phenotypic presentations including flat irregular pigment epithelial detachment (FIPED) and shallow irregular retinal pigment epithelial elevation. These signs are often associated with vascularized lesions that demonstrate increased DLS thickness, irregular contours, and heterogeneous reflectivity. OCTA offers superior sensitivity and specificity for detecting subclinical macular neovascularization compared to dye-based angiography, which may underestimate nonexudative neovascularization. Additionally, indocyanine green angiography remains crucial for identifying branching vascular networks and polypoidal lesions, especially in polypoidal choroidal vasculopathy. In pachychoroid diseases, such as chronic central serous chorioretinopathy, the presence of FIPED/DLS can indicate underlying neovascularization, which may benefit from combination therapy with anti-vascular endothelial growth factor agents. We discuss the multimodal imaging characteristics, prognostic significance, and clinical relevance of DLS across various retinal and chorioretinal disorders.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"71 2","pages":"Pages 456-466"},"PeriodicalIF":5.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-10-01DOI: 10.1016/j.survophthal.2025.09.024
Sepehr Feizi MD, MSc, Firouze Hatami MD, Sina Khosravi Mirzaei MD, Kia Bayat MD
A substantial number of corneal transplantations are performed in the vascularized and inflamed environments of high-risk recipients, which increases the risk of graft rejection. Managing high-risk keratoplasty is challenging and encompasses numerous pre-, intra-, and post-operative measures. Preoperative measures include treating ocular surface inflammation and corneal neovascularization. Intraoperative measures mainly involve performing lamellar keratoplasty, if possible, to reduce the loads of alloantigens introduced to the recipient’s immune system. The key step in the prevention of immunologic rejection in high-risk recipients is the administration of topical and systemic immunosuppressive medications for a long term. Topical corticosteroids are frequently administered after corneal transplantation; however, they are insufficient to prevent graft rejection following high-risk keratoplasty. In such cases, various systemic immunosuppressive medications can be employed with inconstant success rates. Nonetheless, these agents can result in potentially serious and sometimes life-threatening adverse reactions. Furthermore, the ideal method of administration, dosage, frequency, and duration of application of these medications have not been identified for individual cases of high-risk keratoplasty. New strategies, including targeted biological treatments and tolerance-inducing protocols, may hold promise in decreasing the risk of corneal graft rejection in high-risk settings without the adverse reactions of systemic immunosuppressive treatment.
{"title":"Medical and surgical approaches to prevent corneal graft rejection in high-risk recipients","authors":"Sepehr Feizi MD, MSc, Firouze Hatami MD, Sina Khosravi Mirzaei MD, Kia Bayat MD","doi":"10.1016/j.survophthal.2025.09.024","DOIUrl":"10.1016/j.survophthal.2025.09.024","url":null,"abstract":"<div><div>A substantial number of corneal transplantations are performed in the vascularized and inflamed environments of high-risk recipients, which increases the risk of graft rejection. Managing high-risk keratoplasty is challenging and encompasses numerous pre-, intra-, and post-operative measures. Preoperative measures include treating ocular surface inflammation and corneal neovascularization. Intraoperative measures mainly involve performing lamellar keratoplasty, if possible, to reduce the loads of alloantigens introduced to the recipient’s immune system. The key step in the prevention of immunologic rejection in high-risk recipients is the administration of topical and systemic immunosuppressive medications for a long term. Topical corticosteroids are frequently administered after corneal transplantation; however, they are insufficient to prevent graft rejection following high-risk keratoplasty. In such cases, various systemic immunosuppressive medications can be employed with inconstant success rates. Nonetheless, these agents can result in potentially serious and sometimes life-threatening adverse reactions. Furthermore, the ideal method of administration, dosage, frequency, and duration of application of these medications have not been identified for individual cases of high-risk keratoplasty. New strategies, including targeted biological treatments and tolerance-inducing protocols, may hold promise in decreasing the risk of corneal graft rejection in high-risk settings without the adverse reactions of systemic immunosuppressive treatment.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"71 2","pages":"Pages 674-684"},"PeriodicalIF":5.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145226019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-09-20DOI: 10.1016/j.survophthal.2025.09.013
Paola Saboya-Galindo , Carlos Cifuentes-González , William Rojas-Carabali , Germán Mejía-Salgado , Yong Le Tong , Ikhwanuliman Putera , Xin Ying Rachel Song , Cheong Fu Yuan Walter , Zhang Shengjuan , Reo Chan , Rina La Distia Nora , Jyotirmay Biswas , Sapna Gangaputra , Jose S Pulido , John H Kempen , Quan Dong Nguyen , Alejandra de-la-Torre , Vishali Gupta , James T. Rosenbaum , Rupesh Agrawal , Uwe Pleyer
This systematic review evaluates clinical trials and quasi-experimental studies reporting diagnostic criteria, disease activity scoring systems (including Disease Activity Index (DAI), Total Inflammatory Activity Index (TIAI), and Total Adjusted Disease Activity Index (TADAI), and others), and therapeutic strategies used in noninfectious retinal vasculitis (RV), aiming to consolidate current evidence on treatment response and effectiveness measures. Of 5533 articles screened (PROSPERO: CRD42023489232), 15 studies met the inclusion criteria. Most were conducted in Asia (73.3 %) and focused on Behçet disease (60 %) or Eales disease (27 %). RV was diagnosed clinically in all studies, while half incorporated fluorescein angiography to confirm vascular inflammation through leakage, staining, or occlusion; however, definitions of RV were highly variable, often inferred rather than explicitly stated, and lacked standardization. This diagnostic inconsistency, combined with limited imaging data, undermines comparability across studies. Disease activity was assessed using outdated composite indices such as the DAI, TIAI, and TADAI, which lack external validation and fail to capture key clinical features such as macular ischemia or capillary non-perfusion. Best corrected visual acuity, although frequently reported, was confounded by unrelated factors such as cataracts or macular scarring. Therapeutic strategies included systemic corticosteroids, immunosuppressants (e.g., methotrexate, azathioprine), and biologics (e.g., infliximab, interferon-alpha). Treatment selection was heterogeneous, and several regimens—such as cyclophosphamide-azathioprine combinations—do not align with current standards of care. Due to variability in study design and outcome reporting, no pooled effect estimates, or statistical comparisons were conducted. Treatment outcomes were synthesized descriptively based on individual study findings. Current evidence in RV clinical trials is outdated and lacks diagnostic and therapeutic standardization. There is a particular need for RV-specific definitions, validated disease activity and response indices, and contemporary therapeutic trials to guide clinical management and improve outcome comparability.
{"title":"Clinical trials and quasi-experimental studies in the treatment of noninfectious retinal vasculitis: A systematic review from the International Uveitis Study Group (IUSG) Retinal Vasculitis Study (ReViSe) – Report 4","authors":"Paola Saboya-Galindo , Carlos Cifuentes-González , William Rojas-Carabali , Germán Mejía-Salgado , Yong Le Tong , Ikhwanuliman Putera , Xin Ying Rachel Song , Cheong Fu Yuan Walter , Zhang Shengjuan , Reo Chan , Rina La Distia Nora , Jyotirmay Biswas , Sapna Gangaputra , Jose S Pulido , John H Kempen , Quan Dong Nguyen , Alejandra de-la-Torre , Vishali Gupta , James T. Rosenbaum , Rupesh Agrawal , Uwe Pleyer","doi":"10.1016/j.survophthal.2025.09.013","DOIUrl":"10.1016/j.survophthal.2025.09.013","url":null,"abstract":"<div><div>This systematic review evaluates clinical trials and quasi-experimental studies reporting diagnostic criteria, disease activity scoring systems (including Disease Activity Index (DAI), Total Inflammatory Activity Index (TIAI), and Total Adjusted Disease Activity Index (TADAI), and others), and therapeutic strategies used in noninfectious retinal vasculitis (RV), aiming to consolidate current evidence on treatment response and effectiveness measures. Of 5533 articles screened (PROSPERO: CRD42023489232), 15 studies met the inclusion criteria. Most were conducted in Asia (73.3 %) and focused on Behçet disease (60 %) or Eales disease (27 %). RV was diagnosed clinically in all studies, while half incorporated fluorescein angiography to confirm vascular inflammation through leakage, staining, or occlusion; however, definitions of RV were highly variable, often inferred rather than explicitly stated, and lacked standardization. This diagnostic inconsistency, combined with limited imaging data, undermines comparability across studies. Disease activity was assessed using outdated composite indices such as the DAI, TIAI, and TADAI, which lack external validation and fail to capture key clinical features such as macular ischemia or capillary non-perfusion. Best corrected visual acuity, although frequently reported, was confounded by unrelated factors such as cataracts or macular scarring. Therapeutic strategies included systemic corticosteroids, immunosuppressants (e.g., methotrexate, azathioprine), and biologics (e.g., infliximab, interferon-alpha). Treatment selection was heterogeneous, and several regimens—such as cyclophosphamide-azathioprine combinations—do not align with current standards of care. Due to variability in study design and outcome reporting, no pooled effect estimates, or statistical comparisons were conducted. Treatment outcomes were synthesized descriptively based on individual study findings. Current evidence in RV clinical trials is outdated and lacks diagnostic and therapeutic standardization. There is a particular need for RV-specific definitions, validated disease activity and response indices, and contemporary therapeutic trials to guide clinical management and improve outcome comparability.</div></div>","PeriodicalId":22102,"journal":{"name":"Survey of ophthalmology","volume":"71 2","pages":"Pages 545-559"},"PeriodicalIF":5.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}